Intrinsic defects in the T-Cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse

Diabetes

Volumn 50, Issue 12, 2001, Pages 2691-2699

  Yang, Yang ^a   Bao, Min ^a   Yoon, Ji Won ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; RECEPTORS, ANTIGEN, T CELL, ALPHA BETA; RECEPTORS, INTERLEUKIN 2;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE COUNT; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NATURAL KILLER CELL; PATHOLOGY; SPLEEN; T LYMPHOCYTE; THYMUS;

ANIMAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD44; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOKINES; DIABETES MELLITUS, INSULIN-DEPENDENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE COUNT; MICE; MICE, INBRED AKR; MICE, INBRED NOD; MICE, SCID; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-2; SPLEEN; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0035653507     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.12.2691     Document Type: Article

References (57)

1. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
2. Delovitch TL, Singh B: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738, 1997 (published erratum appears in Immunity 8:531, 1998)
3. Serreze DV, Leiter EH: Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol 6:900-906, 1994
4. Wong FS, Janeway CA Jr: The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse. Res Immunol 148:327-332, 1997
5. Yoon JW, Jun HS, Santamaria P: Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27:109-122, 1998
6. Serreze DV, Gaskins HR, Leiter EH: Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543, 1993
7. Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD: B-cells are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med 184:2049-2053, 1996
8. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A: B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46:941-946, 1997
9. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW: The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 189:347-358, 1999
10. Rapoport MJ, Lazarus AH, Jaramillo A, Speck E, Delovitch TL: Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med 177:1221-1226, 1993
11. Colucci F, Bergman ML, Penha-Goncalves C, Cilio CM, Holmberg D: Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci U S A 94:8670-8674, 1997
12. Serreze DV, Leiter EH: Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J Immunol 140:3801-3807, 1988
13. Boitard C, Yasunami R, Dardenne M, Bach JF: T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169:1669-1680, 1989
14. + suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun 9:331-339, 1996
15. + beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med 182:87-97, 1995
16. - thymocytes. J Autoimmun 10:279-285, 1997
17. +-like thymocytes in the NOD mouse. Eur J Immunol 26:2989-2998, 1996
18. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46:572-582, 1997
19. Falcons M, Young B, Tucker L, Rodriguez E, Sarvetnick N: A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med 190:963-972, 1999
20. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA: Extreme Th1 bias of invariant Vα24αQ T cells in type 1 diabetes. Nature 391:177-181, 1998
21. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 179:1285-1295, 1994
22. + T cells are a potential source of IL-4 during primary immune response. J Immunol 155:4544-4550, 1995
23. Takeda K, Dennert G: The development of autoimmunity in C57BL/6 1pr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 177:155-164, 1993
24. + T cells in a TH2 response and in immunoglobulin E production. Science 270:1845-1847, 1995
25. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L: Cutting edge: activation of NK T cells by CDId and alpha- galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 163:2373-2377, 1999
26. Cui J, Watanabe N, Kawano T, Yamashita M, Kamata T, Shimizu C, Kimura M, Shimizu E, Koike J, Koseki H, Tanaka Y, Taniguchi M, Nakayama T: Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J Exp Med 190:783-792, 1999
27. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 187:1047-1056, 1998
28. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF, Monteiro RC: Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 188:1831-1839, 1998
29. Charlton B, Taylor-Edwards C, Tisch R, Fathman CG: Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J Autoimmun 7:549-560, 1994
30. Yang Y, Charlton B, Shimada A, Dal Canto R, Fathman CG: Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4:189-194, 1996
31. Yoon JW, Rodrigues MM, Currier C, Notkins AL: Long-term complications of virus-induced diabetes mellitus in mice. Nature 296:566-569, 1982
32. + T cells by Mtv-3 from the nonobese diabetic mouse. J Immunol 148:2097-2102, 1992 (published erratum appears in J Immunol 149:745 1992)
33. + T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation. J Immunol 162:5156-5163, 1999
34. Falcons M, Lee J, Patstone G, Young B, Sarvetnick N: B-cells are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161:1163-1168, 1998
35. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM: B-cells are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161:3912-3918, 1998
36. + T-cells. Science 268:863-865, 1995
37. Godfrey DI, Zlotnik A: Control points in early T-cell development. Immunol Today 14:547-553, 1993
38. - thymocyte differentiation. J Immunol 152:4783-4792, 1994
39. Wu L, Li CL, Shortman K: Thymic dendritic cell precursors: relationship to the T-cell lineage and phenotype of the dendritic cell progeny. J Exp Med 184:903-911, 1996
40. Shortman K, Vremec D, Corcoran LM, Georgopoulos K, Lucas K, Wu L: The linkage between T-cell and dendritic cell development in the mouse thymus. Immunol Rev 165:39-46, 1998
41. - murine thymocytes positively selected by class I molecules. J Exp Med 180:653-661, 1994
42. + thymocytes. Int Immunol 9:73-4550, 1997
43. + T cell-defective IL-4 production in the non-obese diabetic mouse. Int Immunol 8:1751-1758, 1996
44. + T cells by CD1-expressing cortical thymocytes. J Exp Med 182:2091-2096, 1995
45. Gadue P, Morton N, Stein PL: The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med 190:1189-1196, 1999
46. Walunas TL, Wang B, Wang CR, Leiden JM: Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J Immunol 164:2857-2860, 2000
47. Sullivan KE, Piliero LM, Dharia T, Goldman D, Petri MA: 3′ polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Hum Mutat 16:449-450, 2000
48. Lantz O, Sharara LI, Tilloy F, Andersson A, DiSanto JP: Lineage relationships and differentiation of natural killer (NK) T cells: intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules. J Exp Med 185:1395-1401, 1997
49. Moore TA, von Freeden-Jeffry U, Murray R, Zlotnik A: Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. J Immunol 157:2366-2373, 1996
50. Kanagawa O, Martin SM, Vaupel BA, Carrasco-Marin E, Unanue ER: Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc Natl Acad Sci U S A 95:1721-1724, 1998
51. Schmidt D, Verdaguer J, Averill N, Santamaria P: A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 186:1059-1075, 1997
52. Ridgway WM, Fasso M, Fathman CG: A new look at MHC and autoimmune disease. Science 284:749-751, 1999
53. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH: Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 180:1553-1558, 1994
54. Serreze DV, Bridgett M, Chapman HD, Chen E, Richard SD, Leiter EH: Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin. J Immunol 160:1472-1478, 1998
55. Serreze DV: Autoimmune diabetes results from genetic defects manifest by antigen presenting cells. FASEB J 7:1092-1096, 1993
56. Serreze DV, Gaedeke JW, Leiter EH: Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci U S A 90:9625-9629, 1993
57. Piganelli JD, Martin T, Haskins K: Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 47:1212-1218, 1998